| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 327 |
| 1 | PREDNISONE | 171 |
| 2 | METHOTREXATE SODIUM | 168 |
| 3 | ADALIMUMAB | 165 |
| 4 | LEFLUNOMIDE | 145 |
| 5 | METHOTREXATE | 144 |
| 6 | INFLIXIMAB | 143 |
| 7 | ETANERCEPT | 140 |
| 8 | ACETAMINOPHEN | 137 |
| 9 | RITUXIMAB | 134 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 29 | 0.0084 |
| 1 | AMISULPRIDE | 29 | 0.0047 |
| 2 | ALEMTUZUMAB | 65 | 0.0034 |
| 3 | DIMENHYDRINATE | 35 | 0.0033 |
| 4 | DICLOFENAC POTASSIUM TABLETS | 27 | 0.0031 |
| 5 | ERGOCALCIFEROL | 84 | 0.0028 |
| 6 | CLOZAPINE | 327 | 0.0026 |
| 7 | GOLIMUMAB | 32 | 0.0025 |
| 8 | DICLOFENAC POTASSIUM | 27 | 0.0024 |
| 9 | CALCIUM GLUCONATE | 28 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 383 |
| 1 | Corticosteroid [EPC] | 296 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 262 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 216 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 150 |
| 5 | Aminosalicylate [EPC] | 147 |
| 6 | Antirheumatic Agent [EPC] | 145 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 145 |
| 8 | Benzodiazepine [EPC] | 133 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 130 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 11 | 0.0160 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 29 | 0.0037 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 65 | 0.0034 |
| 3 | Provitamin D2 Compound [EPC] | 84 | 0.0028 |
| 4 | Interferon alfa-2b [EPC] | 4 | 0.0022 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 7 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 9 | 0.0015 |
| 8 | Aminosalicylate [EPC] | 147 | 0.0015 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |